Treatment of Benign Adnexal Tumors in Birt–Hogg–Dubé Syndrome With Surgical Debulking in Combination With Fractional and Fully Ablative Carbon Dioxide Laser Resurfacing No abstract available

Commentary on Retention Rates Among Patients Undergoing Multimodal Facial Rejuvenation Treatment Versus a Single-Modal Treatment in Cosmetic Dermatology Practices No abstract available

Surgical Treatment of Intermammary Hidradenitis Suppurativa With a 3-Point Advancement Flap (Mercedes Closure) No abstract available

Retention Rates Among Patients Undergoing Multimodal Facial Rejuvenation Treatment Versus a Single Monotherapy in Cosmetic Dermatology Practices BACKGROUND Facial aging is a multifactorial process. Accordingly, expert opinion has largely been unanimous in that multimodal treatment targeting various aspects of the aging face provides superior results. However, there is a lack of studies exploring patient response. OBJECTIVE To compare patient retention between triple multimodal facial rejuvenation treatment (neuromodulator, filler, and energy-based therapy) and monotherapy (neuromodulator alone). METHODS A retrospective, multicenter (the United States, Canada, and Germany) study was performed. Cases were retrieved from July 2015 to June 2016. The study compared patients who had undergone monotherapy (neuromodulator), combined multimodal treatment (neuromodulator, filler, and energy-based therapy on the same day), and sequential multimodal treatment (neuromodulator, filler, and energy-based therapy over a 1-year period). Retention rates were calculated. RESULTS A total of 509 patients were included: monotherapy (300), sequential multimodal treatment (93), and combined multimodal treatment (116). Patient retention was significantly higher in the combined multimodal treatment group compared with the monotherapy and sequential multimodal treatment groups (p < .001). Subgroup analysis revealed similar trends at all sites. CONCLUSION Based on retention rates, patients are more likely to return to the clinic when multiple treatment modalities are used during 1 encounter. These data further solidify the importance of multimodal therapy for both the provider and the patient. Address correspondence and reprint requests to: Allison Gregory, MD, Department of Dermatology and Skin Science, University of British Columbia, 835 W 10th Ave, Vancouver, British Columbia, Canada, V5Z 4E8, or e-mail: allison.gregory@medportal.ca S. Humphrey is a consultant for Allergan, Galderma, Merz, and Revance. S. Fabi is a consultant for Allergan and Merz. The remainin authors have indicated no significant interest with commercial supporters. © 2019 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.

Improvement of Radial Cheek Lines With Hyaluronic Acid–Based Dermal Filler VYC-17.5L: Results of the BEAM Study BACKGROUND Radial cheek lines (RCL) may convey an older, potentially less attractive appearance. OBJECTIVE To evaluate the effectiveness of hyaluronic acid–based dermal filler VYC-17.5L for correcting RCL. MATERIALS AND METHODS Fifty-three women (40–65 years) received injections of VYC-17.5L in both cheeks on Day 1 (optional Day 14 touch-up). Effectiveness was evaluated on Day 45 by subject-rated dynamic RCL improvement (Global Aesthetic Improvement Scale [GAIS]; primary end point) and independent, noninjecting investigator–rated GAIS; subject Self-Perception of Age (SPA); subject-assessed satisfaction with and natural look of treatment; and instrument-assessed changes in static and dynamic RCL roughness, amplitude, and texture (secondary end points). Safety assessments included injection site responses (ISRs). RESULTS On Day 45, 98% of subjects rated RCL as improved or much improved (investigator rated: 95%). Subjects with same or older SPA before treatment (n = 38) perceived themselves as 2.0 and 5.5 average years younger after treatment, respectively. Day 45 mean satisfaction with and natural look of treated areas was 7.9/10 and 7.2/10, respectively. Treatment significantly improved RCL roughness, amplitude, and texture (all p < .001). Most common ISRs were hematoma (35.9%), bruising (30.2%), and irregularities/bumps (22.6%); most ISRs were mild. CONCLUSION VYC-17.5L effectively corrected dynamic RCL, improved instrument-assessed indicators of skin quality, and resulted in younger age perception. Address correspondence and reprint requests to: Patricia Ogilvie, MD, SkinConcept, Theatinerstraße 46, Munich 80333, Germany, or e-mail: dr.patricia.ogilvie@skin-concept.de Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the full text and PDF versions of this article on the journal's Web site (www.dermatologicsurgery.org). This study was sponsored by Allergan plc, Dublin, Ireland. Editorial assistance was provided to the authors by Peloton Advantage, an OPEN Health company, Parsippany, NJ, and was funded by Allergan plc. P. Ogilvie, B. Fink, C. Leys, S. Lipko-Godlewska, and F. Niforos are investigators for Allergan plc, Marlow, United Kingdom. G. Kerson and M. Silberberg are employees of Allergan plc, Marlow, United Kingdom. R. Kelly provided writing services to the authors, which was funded by Allergan plc. © 2019 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.

Treatment of Necrobiosis Lipoidica With Pulsed Dye Laser No abstract available

Managing and Reducing Office Expenses in Dermatology Surgery No abstract available

Autologous Fat Grafting for Correction of Intramuscular Corticosteroid Injection–Induced Fat Atrophy No abstract available

Successful Treatment of Milia in Skin of Color (FST IV-VI) With Variable Short-Pulse Er: YAG Laser Vaporization No abstract available

Split-Face Study of the Efficacy and Persistence of Reconstituted and Refrigerated PrabotulinumtoxinA No abstract available